Cytokeratin 13 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cytokeratin 13 monoclonal antibodies for research applications. Cytokeratin 13 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytokeratin 13 is a type of intermediate filament protein primarily expressed in the epithelial cells of the oral cavity, esophagus, and other stratified squamous epithelia. Cytokeratin 13 plays a crucial role in maintaining the structural integrity and mechanical resilience of epithelial tissues. Understanding Cytokeratin 13 expression patterns helps researchers investigate normal tissue development and disease progression. Cytokeratin 13 serves as a key marker for studying epithelial cell differentiation and tissue-specific functions. Monitoring Cytokeratin 13 levels provides insights into various pathological conditions affecting epithelial tissues. Research utilizing Cytokeratin 13 monoclonal antibodies advances understanding of cellular organization and tissue maintenance. Santa Cruz Biotechnology monoclonal antibodies for Cytokeratin 13 enable researchers worldwide to advance scientific knowledge in epithelial biology and disease mechanisms.